Aktis Oncology Inc. began trading on the Nasdaq Global Select Market under the ticker symbol "AKTS" on January 9, 2026, pricing its shares at $18 each.
The company offered 17.65 million shares in its IPO, with gross proceeds expected to be roughly $318.0 million. The underwriters have a 30-day option to purchase up to an additional 2.647 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.